Article
Paris - New options for treatment and prevention of severe drug eruptions are likely on the horizon thanks to recent advances in understanding the mechanisms of these reactions, Jean-Claude Roujeau, M.D., said at the World Congress of Dermatology.
The Weekly Roundup: September 30-October 4
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAAD
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
9 Months of Treatment With Tralokinumab Results in Improved QoL, Itch, and Sleep
Thyroid Disorders and Their Link to Alopecia Areata